MHUA vs. MGRM, NSPR, APYX, CTCX, DRIO, NUVO, SEPA, CTSO, LNSR, and LUCD
Should you be buying Meihua International Medical Technologies stock or one of its competitors? The main competitors of Meihua International Medical Technologies include Monogram Orthopaedics (MGRM), InspireMD (NSPR), Apyx Medical (APYX), Carmell (CTCX), DarioHealth (DRIO), Holdco Nuvo Group D.G (NUVO), SEP Acquisition (SEPA), Cytosorbents (CTSO), LENSAR (LNSR), and Lucid Diagnostics (LUCD). These companies are all part of the "surgical & medical instruments" industry.
Monogram Orthopaedics (NASDAQ:MGRM) and Meihua International Medical Technologies (NASDAQ:MHUA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking.
In the previous week, Meihua International Medical Technologies had 1 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 4 mentions for Meihua International Medical Technologies and 3 mentions for Monogram Orthopaedics. Meihua International Medical Technologies' average media sentiment score of 1.88 beat Monogram Orthopaedics' score of 1.48 indicating that Monogram Orthopaedics is being referred to more favorably in the media.
Monogram Orthopaedics and Meihua International Medical Technologies both received 0 outperform votes by MarketBeat users.
Meihua International Medical Technologies has higher revenue and earnings than Monogram Orthopaedics.
Monogram Orthopaedics' return on equity of 0.00% beat Meihua International Medical Technologies' return on equity.
0.5% of Monogram Orthopaedics shares are held by institutional investors. Comparatively, 1.2% of Meihua International Medical Technologies shares are held by institutional investors. 32.1% of Monogram Orthopaedics shares are held by insiders. Comparatively, 66.6% of Meihua International Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Meihua International Medical Technologies beats Monogram Orthopaedics on 7 of the 9 factors compared between the two stocks.
Get Meihua International Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for MHUA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MHUA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Meihua International Medical Technologies Competitors List
Related Companies and Tools
